Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Childrens Cancer Group.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Clinical Oncology

• Publication date

  1993-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.1993.11.3.538PMID 8445429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study.

  1991cited by this paper
• The role of timing of high‐dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia

  1990cited by this paper
• Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group.

  1990cited by this paper
• Improvement in outcome for children with acute nonlymphocytic leukemia. A report from the childrens cancer study group

  1989cited by this paper
• High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results.

  1989cited by this paper
• Acute myelogenous leukemia: recent advances in therapy.

  1987cited by this paper
• Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.

  1987cited by this paper
• Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemia.

  1985cited by this paper
• Post-remission therapy in acute myeloid leukemia.

  1985cited by this paper
• High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study.

  1985cited by this paper
• Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.

  1984cited by this paper
• Contrasting benefits of two maintenance programs following identical induction in children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group.

  1984cited by this paper
• Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison.

  1984cited by this paper
• Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update.

  1983cited by this paper
• Marrow transplantation for children with acute nonlymphoblastic leukemia in first remission.

  1981cited by this paper
• Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6-thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy.

  1978cited by this paper

• Non-Canonical, Strongly Selective Protein Disulfide Isomerases as Anticancer Therapeutic Targets

  2025cites this paper
• Mechanistic insights into L-asparaginase resistance in cancers.

  2025cites this paper
• Study of the intestinal microbiota composition and the effect of treatment with intensive chemotherapy in patients recovered from acute leukemia

  2024cites this paper
• Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia

  2023cites this paper
• Amino Acid Metabolism in Acute Myeloid Leukemia

  2021cites this paper
• Outcomes of intensification of induction chemotherapy for children with high‐risk acute myeloid leukemia: A report from the Children's Oncology Group

  2021cites this paper
• Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias

  2021cites this paper
• Comparative effectiveness of different consolidation chemotherapy regimens for pediatric acute lymphoblastic leukemia

  2020cites this paper
• Myelogenous

  2020cites this paper
• Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy.

  2019cites this paper
• Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias

  2019cites this paper
• Acute myeloid leukaemia niche regulates response to L‐asparaginase

  2019cites this paper
• Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias

  2018cites this paper
• Caracterització de les alteracions moleculars de FLT3 en pacients pediàtrics afectes de leucèmia aguda. Correlació amb l’activitat i expressió dels transportadors de fàrmacs derivats de nucleòsids

  2017cites this paper
• A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML

  2017cites this paper
• Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia.

  2016cites this paper
• Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials.

  2016cites this paper
• Maintenance Therapy for Acute Myelogenous Leukaemia

  2016cites this paper
• Asparaginase in the treatment of non-ALL hematologic malignancies

  2014cites this paper
• Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: A report from the children's oncology group

  2014cites this paper
• Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia

  2013cites this paper
• adolescents: recommendations from an international expert panel Diagnosis and management of acute myeloid leukemia in children and

  2013cites this paper
• Children's Oncology Group untreated pediatric acute myeloid leukemia (AML): a report from the Outcomes in CCG-2961, a Children's Oncology Group phase 3 trial for

  2013cites this paper
• Acute myeloid leukemia commentary

  2013cites this paper
• Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

  2012cites this paper
• Childhood acute myeloid leukaemia

  2012cites this paper
• Myeloid Leukemia, Myelodysplasia, and Myeloproliferative Disease in Children

  2009cites this paper
• Twenty years of follow‐up among survivors of childhood and young adult acute myeloid leukemia

  2008cites this paper
• Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.

  2008cites this paper
• Childhood cancer survival in France, 1990-1999.

  2008cites this paper
• Outcomes in childhood AML in the absence of transplantation in first remission—Children's Cancer Group (CCG) studies 2891 and CCG 213

  2008cites this paper
• Treatment, Outcomes, and Challenges of Newly Diagnosed AML in Children and Adolescents

  2007cites this paper
• The Development of a Novel Protocol for the Treatment of De Novo Childhood Acute Myeloid Leukemia in a Single Institution in Taiwan

  2007cites this paper
• Improved treatment results for childhood acute myeloid leukemia in Taiwan

  2006cites this paper
• Akute myeloische Leukämien

  2006cites this paper
• High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.

  2006cites this paper
• Perspectivas para a leucemia mielóide aguda na infância após a observação de um grupo de pacientes tratados convencionalmente

  2006cites this paper
• Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit – multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group

  2005cites this paper
• Myeloprotective effect of short‐course high‐dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia

  2005cites this paper
• Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

  2005cites this paper
• Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.

  2004cites this paper
• Increased risk of chronic hepatitis in children with cancer.

  2003cites this paper
• Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.

  2003cites this paper
• Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

  2003cites this paper
• Treatment of Acute Myeloid Leukemia in Children

  2003cites this paper
• Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant.

  2002cites this paper
• Treatment of Common Childhood Malignancies

  2002cites this paper
• SCID Mouse Models of Human Leukemia and Lymphoma as Tools for New Agent Development

  2002cites this paper
• Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

  2002cites this paper
• What is the optimal therapy for childhood AML?

  2002cites this paper
• Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

  2001cites this paper
• A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.

  2001cites this paper
• Acute Myeloid Leukemia (AML) in Children: Results of the French Trials

  2001cites this paper
• Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia.

  2000cites this paper
• Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's cancer group study CCG-2891.

  2000cites this paper
• Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia.

  2000cites this paper
• Cytarabine 大量療法 (HD-AraC) 後におけるα-Streptococcus敗血症とその対策

  1998cites this paper
• Acute myeloid leukaemias.

  1998cites this paper
• High‐dose cytarabine‐containing chemotherapy with or without granulocyte colony‐stimulating factor for children with acute leukemia

  1998cites this paper
• Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group.

  1998cites this paper
• A supremum version of logrank test for detecting late occurring survival differences

  1998cites this paper
• Immobilization of L‐asparaginase into a biocompatible poly(ethylene glycol)‐albumin hydrogel: evaluation of performance in vivo

  1997cites this paper
• Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council.

  1997cites this paper
• Diagnosis and treatment of childhood acute myelogenous leukemia.

  1997cites this paper
• Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission

  1997cites this paper
• Childrens Cancer Group Studies in Acute Myeloid Leukemia, 1979–1995: Three Strategies That Have Worked

  1997cites this paper
• Prognostic Factors and Treatment in Pediatric Acute Myeloblastic Leukemia: French Trials

  1997cites this paper
• High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia

  1997cites this paper
• Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).

  1996cites this paper
• Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.

  1996cites this paper
• Diagnosis and treatment of acute myelogenous leukemia in childhood.

  1996cites this paper
• Mitoxantrone-containing regimen for treatment of childhood acute leukemia (AML) and analysis of prognostic factors: results of the EORTC Children Leukemia Cooperative Study 58872.

  1996cites this paper
• Therapy of childhood acute myelogenous leukemias

  1996cites this paper
• Allogeneic and autologous bone marrow transplantation in AML in first remission. The Spanish experience.

  1996cites this paper
• Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).

  1996cites this paper
• Immobilization of L‐asparaginase into a biocompatible poly(ethylene glycol)‐albumin hydrogel: I: Preparation and in vitro characterization

  1996cites this paper
• Acute myeloid leukaemia.

  1996cites this paper
• Infections in Children with Acute Myelogenous Leukemia: Concepts of Management and Prevention

  1995cites this paper
• Treatment of Patients with Acute Myelogenous Leukemia: Review of Clinical Trials of the Past Decade

  1995cites this paper
• Group sequential methods for comparison of cure rates in clinical trials.

  1995cites this paper
• Bone Marrow Transplantation for Children with Acute Myelogenous Leukemia

  1995cites this paper
• Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.

  1994cites this paper
• Group Duration Analysis of the Proportional Hazard Model: Minimum Chi-squared Estimators and Specification Tests

  1994cites this paper
• Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group study.

  1994cites this paper
• Childhood Acute Myeloid Leukemia in Mice With Severe Combined Immunodeficiency

  1994cites this paper
• Childhood acute myeloid leukemia in mice with severe combined immunodeficiency.

  1994cites this paper
• Cytosine arabinoside and mitoxantrone induction chemotherapy followed by bone marrow transplantation or chemotherapy for relapsed or refractory pediatric acute myeloid leukemia.

  1994cites this paper
• Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood.

  1994cites this paper
• Media Review: Videotapes

  1993cites this paper